A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT05923008 · RECRUITING
Trial details
- NCT number
- NCT05923008
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-14
- Primary completion
- 2024-11-30
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.